Medical cannabis evidence remains more limited than many patients expect. A large JAMA review of over 2,500 studies highlights where clinical support exists and where it does not. This analysis clarifies what current medical cannabis evidence can responsibly support in practice.
CBN trims rates on longer-dated T-Bill as investors pile N2.7tn – Businessday NG
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical EducationCannabinoid ScienceClinical Practice Why This MattersThis news item appears to be about Central...
Cannabis Wellness Frontiers: 6 Emerging Areas Worth Watching, and What the Evidence Actually Shows
Cannabis research keeps expanding, but not every promising idea deserves the same level of confidence. This physician-guided review explores six emerging cannabis wellness frontiers, including wound healing, endometriosis, trauma, brain injury recovery, menopause, intimacy, and creativity, with clear boundaries around what the evidence does and does not show
New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …
WHY IT MATTERS: As federal rescheduling moves forward, organizations that center both clinical evidence and patient experience could directly shape whether patients gain broader, safer, and more affordable access to cannabinoid therapies. CLINICAL OVERVIEW: A newly formed cannabis medicine group is working to ensure that federal policy discussions around cannabinoid therapy are rooted in scientific evidence and shaped by real patient perspectives. This effort comes at a critical moment as rescheduling conversations advance at the federal level, creating an opening to influence how cannabis is regulated, researched, and integrated into clinical care.
7 Crucial Facts About Medical Cannabis Safety for 2024
Medical cannabis is showing promise in treating a variety of symptoms without compromising cognitive health, but understanding its long-term safety is key. A recent study reveals that light to moderate use of cannabis may not impair cognition over one year, but issues like tolerance and dose escalation remain concerns for the future.
Cannabinomics: A novel approach to differentiating cannabis varieties
A recent study surveyed twenty varieties of cannabis using a novel technique that they refer to as cannabinomics. This technique employs mass spectrometry of the entire metabolome along with statistical analysis as...